MAPT and Parkinson disease: These results found a significant correlation of the levels of α-synuclein with the levels of T-tau and P-tau181 and found that measures of CSF Aβ1-42, T-tau, P-tau181, and α-SN have prognostic and diagnostic potential in early-stage PD [22].